Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1266

Nov 16, 2020

New technology allows more precise view of the smallest nanoparticles

Posted by in categories: biotech/medical, nanotechnology

Current state-of-the-art techniques have clear limitations when it comes to imaging the smallest nanoparticles, making it difficult for researchers to study viruses and other structures at the molecular level.

Scientists from the University of Houston and the University of Texas M.D. Anderson Cancer Center have reported in Nature Communications a new optical imaging technology for nanoscale objects, relying upon unscattered to detect as small as 25 nanometers in diameter. The technology, known as PANORAMA, uses a glass slide covered with gold nanodiscs, allowing scientists to monitor changes in the and determine the target’s characteristics.

PANORAMA takes its name from Plasmonic Nano-aperture Label-free Imaging (PlAsmonic NanO-apeRture lAbel-free iMAging), signifying the key characteristics of the technology. PANORAMA can be used to detect, count and determine the size of individual dielectric nanoparticles.

Nov 16, 2020

UN Official Warns of “Famines of Biblical Proportions” in 2021

Posted by in categories: biotech/medical, food

2021 may not turn out well.


He’s hoping the world’s billionaires will donate their pandemic profits.

Nov 16, 2020

A Google Brain scientist turns to AI to make medicine more personal

Posted by in categories: biotech/medical, robotics/AI

Maithra Raghu, a research scientist at Google Brain, is betting that neural networks can become a powerful tool in medicine.

Nov 16, 2020

Chronic inflammation causes a reduction in NAD+

Posted by in categories: biotech/medical, life extension

NAD+ (nicotinamide adenine dinucleotide), a key metabolite central to an efficient and healthy metabolism, declines with age. This previously unexplained phenomena is associated with numerous age-related diseases and has spawned the development of many nutritional supplements aimed at restoring NAD+ to more youthful levels. Publishing in Nature Metabolism, researchers at the Buck Institute have identified chronic inflammation as a driver of NAD+ decline. They show that an increasing burden of senescent cells, which is also implicated in the aging process, causes the degradation of NAD via the activation of CD38 (cyclic ADP ribose hydrolase) a protein that is found on the cell membranes both inside and on the surface of many immune cells.

“We are very excited to link two phenomena which have been separately associated with aging and age-related disease,” said Eric Verdin, MD, Buck Institute President and CEO and senior author of the paper. “The fact that NAD+ decline and are intertwined provides a more holistic, systemic approach to aging and the discovery of CD38 macrophages as the mediator of the link between the two gives us a new target for therapeutic interventions.”

Nov 16, 2020

Separate Antiaging Trials for Rapamycin and Metformin

Posted by in categories: biotech/medical, life extension, nanotechnology, robotics/AI, singularity


AgelessRx claims that PEARL is the first nationwide telemedicine trial and one of the first large-scale intervention trials on Longevity. The human trial is a stepping stone to the way to bringing rapamycin to the Longevity market. PEARL (Participatory Evaluation of Aging with Rapamycin for Longevity) is a $600,000 trial with the University of California. They will evaluate the safety and effectiveness of rapamycin in 200 healthy adults for Longevity in double-blind, randomized, placebo-controlled trial.

Interested patients will be screened for eligibility using telemedicine. Eligible patients include those aged 50–85 of any sex, any ethnicity, in relatively good health, with only well-managed, clinically stable chronic diseases.

TAME is a separate $75 million trial to clinically evaluate Metformin drugs for Longevity properties. TAME has a composite primary endpoint – of stroke, heart failure, dementia, myocardial infarction, cancer and death. Rather than attempting to cure one endpoint, it will look to delay the onset of any endpoint, extending the years in which subjects remain in good health – their healthspan. A $40 million donation has been combined with a $35 million NIH grant to fund the TAME trial.

Nov 16, 2020

Pearls may provide new information processing options for biomedical, military innovations

Posted by in categories: biotech/medical, military

Pearls have long been favored as objects of beauty. Now, Purdue University innovators are using the gem to provide potential new opportunities for spectral information processing that can be applied to spectroscopy in biomedical and military applications.

The Purdue team demonstrated transport-assisted information processing by creating a .

Spectrometers probe interactions of matter and light as a function of the electromagnetic spectrum and are commonly used in biomedical and . For example, they have been used for diagnostics of various types of cancer and for military gas sensing.

Nov 15, 2020

Scientists develop next-generation immunotherapy now entering early phase clinical trials

Posted by in category: biotech/medical

Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system, launching a two-pronged response against cancer, according to a study published in Nature Cancer today.

In the study, partly funded by Cancer Research UK, the new immunotherapy , which targets suppressive ‘regulatory’ immune cells inside a tumor, significantly improved long-term survival in animal models even when used without other drugs.

Continue reading “Scientists develop next-generation immunotherapy now entering early phase clinical trials” »

Nov 15, 2020

Chinese firm turns panda poop into toilet paper

Posted by in categories: biotech/medical, business, food

Circa 2017 o.o


When life gave one Chinese company giant panda poop, it decided to make paper — and profits. The Qianwei Fengsheng Paper Company in southwest Sichuan province has teamed up with the China Conservation and Research Center for the Giant Panda to recycle the animal’s faeces and food debris into toilet paper, napkins and other household products, state media reported Wednesday. The goods, soon to be released on the Chinese market, will be marketed as part of a “panda poo” product line decorated with a picture of the bamboo-eating, black-and-white bear. “They’re taking care of our garbage for us,” Huang Yan, a researcher at the giant panda centre, told the Chengdu Business Daily. Huang told Xinhua state news agency that the 10 kilograms (22 pounds) of bamboo poo that adult pandas unleash daily are rich in fibre after absorbing the fructose from the shoots. In addition to their valuable dung, pandas also produce 50 kilograms of food waste every day from the bamboo husks they spit out after chewing. While the process of turning bamboo into paper generally involves the breaking down of fructose to extract fibre, this step naturally occurs in the pandas’ digestive tract, the paper company’s president, Yang Chaolin, told Xinhua. Fengsheng will collect the faeces from three panda bases in Sichuan a couple of times a week. After it is boiled, pasteurised and turned into paper, it will be tested for bacteria before going on sale. Boxes of “panda poo” tissues will be sold at 43 yuan ($6.5) a pop. “Pandas get what they want and we do too,” Yang said. “It’s a win-win.”

Nov 15, 2020

‘He came back from the dead’: Lost Mount Rainier hiker starts to recover after rescue in whiteout conditions

Posted by in category: biotech/medical

It took dozens of park rangers, searchers, doctors and nurses, but Michael Knapinski, who became lost amid freezing, whiteout conditions in Mount Rainier National Park last weekend, was brought back to life in what his medical team is calling a miraculous recovery.

The 45-year-old from Woodinville was on a snowy hike with a friend on the morning of Nov. 7. The two separated below the Muir Snowfield. His friend planned to continue on skis to Camp Muir while Knapinski snowshoed down toward Paradise, where they expected to meet up.

“I was pretty close to the end (of the trail). … Then it turned to whiteout conditions, and I couldn’t see anything,” Knapinski told The Seattle Times in a phone interview Friday. The last thing he said he remembers is taking baby steps down the mountain, surrounded by white.

Nov 15, 2020

Can We Change Our Genes & DNA With Our Thoughts?

Posted by in categories: biotech/medical, materials

A 2002 article published in the American Psychological Association’s prevention & treatment, by University of Connecticut psychology professor Irving Kirsch titled, “The Emperor’s New Drugs,” made some more shocking discoveries. He found that 80 percent of the effect of antidepressants, as measured in clinical trials, could be attributed to the placebo effect. This professor even had to file a Freedom of Information Act (FOIA) request to get information on the clinical trials of the top antidepressants.

A Baylor School of Medicine study, published in 2002 in the New England Journal of Medicine, looked at surgery for patients with severe and debilitating knee pain. Many surgeons know there is no placebo effect in surgery, or so most of them believe. The patients were divided into three groups. The surgeons shaved the damaged cartilage in the knee of one group. For the second group, they flushed out the knee joint, removing all of the material believed to be causing inflammation. Both of these processes are the standard surgeries people go through who have severe arthritic knees. The third group received a “fake” surgery, the patients were only sedated and tricked that they actually had the knee surgery. For the patients not really receiving the surgery, the doctors made the incisions and splashed salt water on the knee as they would in normal surgery. They then sewed up the incisions like the real thing and the process was complete.